Kraig Biocraft Laboratories has successfully completed the first commercial production run of its BAM-1 hybrid spider silk cocoons, launching 30 days ahead of schedule. This achievement follows the overwhelming success of their spring production trials, during which two separate BAM-1 parental lines were raised and cross-mated to produce the BAM-1 hybrids.
The recent production run marks a significant milestone, with a tenfold increase in production volume compared to the spring trials, yielding over 325 pounds of recombinant spider silk cocoons. This is the largest batch of recombinant spider silk cocoons ever produced by the company.
The BAM-1 hybrids were specifically engineered for enhanced robustness to meet the demands of large-scale spider silk manufacturing. With proven production efficiency, Kraig Labs is preparing for further commercial expansion of the BAM-1 parental lines and a significant scale-up of the BAM-1 hybrids, aiming to achieve metric-ton-level spider silk production.
Company Founder and CEO, Kim Thompson, announced that the first commercial rearing of BAM-1 hybrids was a significant success, marking their largest single batch to date. He emphasized that this achievement is just the beginning of an exciting and rapid expansion of spider silk production in 2024. Thompson also highlighted the company's commitment to taking smart risks as they lead the commercialization of cost-effective and eco-responsible spider silk.
